Unit-Dose Radiopharmaceutical Supply (Cardiac Imaging)

The contract is for the supply of Tc-99m Tetrofosmin, commonly known as Myoview, specifically for use in myocardial perfusion imaging, a critical diagnostic procedure in cardiac care. The vendor is responsible for the full lifecycle of the radiopharmaceutical, including precise calibration, sterile unit-dose packaging, and timely delivery to ensure clinical readiness. All services must meet strict regulatory and quality standards to maintain patient safety and imaging accuracy, with packaging requirements tailored for single-dose vial administration in clinical settings. The work is to be performed in Portsmouth, with performance obligations tied to precise timing and traceability protocols inherent to radiopharmaceutical logistics. This subcontract, issued by the Defense Health Agency under the Department of Defense, is classified under NAICS code 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on June 29, 2026, with responses due by July 19, 2026, at 9:00 PM Eastern Time. While the contract does not specify a set-aside for small or disadvantaged businesses, it is structured as a subcontract, indicating it may be part of a larger procurement effort. The delivery window and operational requirements suggest urgency and strict adherence to nuclear medicine supply chain protocols, particularly in a military healthcare context where reliability and consistency are paramount for service members and dependents undergoing diagnostic imaging.